Chronic Pain Market Analysis, Demand And Outlook 2025- 2034

Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Forecasted Market Size of the Chronic Pain Market by 2029?
The chronic pain market size has grown strongly in recent years. It will grow from $78.79 billion in 2024 to $84.66 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to injury and trauma, surgical procedures, inflammatory conditions, nerve damage and neuropathy, lack of effective treatments.

The chronic pain market size is expected to see strong growth in the next few years. It will grow to " $117.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to aging population, telemedicine expansion, public health awareness, genetic research and precision medicine, psychosocial stressors. Major trends in the forecast period include integration of wearable devices, pain education and support groups, holistic pain management, non-opioid pain management, regenerative medicine for pain.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

What Are the Major Growth Drivers for the Chronic Pain Market?
The prevalence of chronic pain patients is expected to propel the growth of the chronic pain market. Chronic pain patients refer to individuals who experience persistent or long-lasting pain that lasts beyond the normal healing process or persists for an extended period, typically exceeding three months. The high prevalence of chronic pain patients drives the growth of the chronic pain market, as the increasing demand for effective pain management solutions, including pharmaceuticals and medical devices, creates opportunities for innovation and development within the industry. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 4.0 million Australians (16% of the population) were living with back problems in 2022. By 2023, back problems became the third leading cause of disease burden, contributing to 4.3% of the country's total disease burden. Additionally, in February 2024, according to another report published by the Institute for Health Metrics and Evaluation, a US-based national and international public health agency and research institute, the projected global cases of neck pain are expected to reach 269 million by 2050 (ranging from 219 to 322 million), representing a 32.5% increase (between 23.9% and 42.3%) compared to 2020. Therefore, the prevalence of chronic pain patients is driving the growth of the chronic pain market.

Which Key Segments Are Included in the Chronic Pain Market Analysis?
The chronic painmarket covered in this report is segmented –

1) By Product: Drug; Devices
2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications
3) By End User: Hospitals; Clinics; Research Organization

Subsegments:
1) By Drug: Non-Opioid Analgesics; Opioids; Antidepressants; Anticonvulsants; Topical Analgesics; Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units; Spinal Cord Stimulators; Intrathecal Drug Delivery Systems; Heat And Cold Therapy Devices; Bioelectronic Devices

Which Emerging Trends Are Shaping the Future of the Chronic Pain Market?
Alternative pain management technologies are a key trend gaining popularity in the chronic pain market. Companies operating in the chronic pain market are focused on developing innovative portable and user-friendly nerve stimulation devices that use electrical impulses to stimulate nerves and reduce pain, providing a non-invasive pain management option, to sustain their position in the market. For instance, in December 2022, Abbott Laboratories, a US-based healthcare company specializing in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals, launched Eterna, a state-of-the-art spinal cord stimulation (SCS) system that is currently the most compact implantable and rechargeable device available in the chronic pain treatment market. Eterna SCS employs Abbott's exclusive low-dose BurstDR stimulation, the sole waveform technology with extensive clinical evidence (1A evidence), demonstrating a 23% greater reduction in pain compared to conventional waveform technology approaches.

Who Are the Leading Market Participants in the Chronic Pain Market?
Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Get the detailed chronic pain market report today
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Which Regions Are Driving the Highest Demand in the Chronic Pain Market?
North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company